Elevance Health, Inc.
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$413.60−6.47 (-1.54%)
Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –
Elevance Health CarelonRx by Year
CarelonRx — Quarterly Adjusted Prescription Scripts (M)
Elevance Health CarelonRx: 88.5M in FY2025, up 6.8% from a year earlier.
Latest, FY2025
88.5
Period ended Dec 31, 2025
Change on a year earlier
+6.8%
82.9 in FY2024
History
5 years
Since FY2021
Sources
3
Documents cited below
Where the FY2025 figure comes from
“|| CarelonRx Quarterly Adjusted Scripts | 88.5 | 82.9 | 78.0 | 5.6 | 6.8 | % | 4.9 | 6.3 | %”
Source: 10-K (FY2025, 2026-02-06) ↗
Retail and mail-order prescription volume with 90-day fills counted as 3 adjusted scripts (Q4 figure shown in 10-K annual column).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | CarelonRx — Quarterly Adjusted Prescription Scripts (M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 88.5 | +6.8% | 10-K (FY2025, 2026-02-06) ↗ |
| FY2024 | Dec 31, 2024 | 82.9 | +6.3% | 10-K (FY2025, 2026-02-06) ↗ |
| FY2023 | Dec 31, 2023 | 78 | -4.9% | 10-K (FY2025, 2026-02-06) ↗ |
| FY2022 | Dec 31, 2022 | 82 | -2,150.0% | 10-K (FY2024, 2025-02-20) ↗ |
| FY2021 | Dec 31, 2021 | -4 | – | 10-K (FY2023, 2024-02-21) ↗ |
Cite this data
StockData. (2026). Elevance Health CarelonRx (M), annual FY2021–FY2025 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/carelonrx-adjusted-scripts
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.